“Caring for life” is the motto of Fresenius Kabi, a global healthcare company that specialises in life-saving medicines and technologies for infusion, transfusion and clinical nutrition. The products and services are used to help care for critically and chronically ill patients.

Through Fresenius Kabi's biosimilar products, which replicate an already approved biologic, the company aims to unlock the potential of high-quality therapies for even more patients, increasing access to affordable, state-of-the-art healthcare. With biosimilars, it offers alternative treatments for diseases such as cancer and autoimmune diseases. Fresenius Kabi is proud to deliver affordable options, especially at a time when worldwide healthcare systems are under intense strain.

The company, which has a UK base in Cheshire, is committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face. The Fresenius chain was founded in 1462, when the Hirsch Pharmacy opened in Frankfurt am Main, Germany. Dr Eduard Fresenius, who specialised in injection solutions, serologic reagents and Bormelin nasal ointment, expanded it.

Further development took place during the 1960s and 1970s with a focus on the development of the first ready-to-use feed tube, which was launched in 1979. For Fresenius Kabi employees, patients are at the forefront of all decisions and actions. Providing the best care for patients is the end goal.